Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

T-bet+ memory B cells: Generation, function, and fate.

Knox JJ, Myles A, Cancro MP.

Immunol Rev. 2019 Mar;288(1):149-160. doi: 10.1111/imr.12736. Review.

PMID:
30874358
2.

T-bet+ B cells: A common denominator in protective and autoreactive antibody responses?

Myles A, Sanz I, Cancro MP.

Curr Opin Immunol. 2019 Apr;57:40-45. doi: 10.1016/j.coi.2019.01.002. Epub 2019 Feb 19. Review.

PMID:
30784957
3.

Strengthening and Institutionalizing the Leadership and Management Role of Frontline Nurses to Advance Universal Health Coverage in Zambia.

Foster AA, Makukula MK, Moore C, Chizuni NL, Goma F, Myles A, Nelson D.

Glob Health Sci Pract. 2018 Dec 27;6(4):736-746. doi: 10.9745/GHSP-D-18-00067. Print 2018 Dec 27.

4.

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

Pardi N, Hogan MJ, Naradikian MS, Parkhouse K, Cain DW, Jones L, Moody MA, Verkerke HP, Myles A, Willis E, LaBranche CC, Montefiori DC, Lobby JL, Saunders KO, Liao HX, Korber BT, Sutherland LL, Scearce RM, Hraber PT, Tombácz I, Muramatsu H, Ni H, Balikov DA, Li C, Mui BL, Tam YK, Krammer F, Karikó K, Polacino P, Eisenlohr LC, Madden TD, Hope MJ, Lewis MG, Lee KK, Hu SL, Hensley SE, Cancro MP, Haynes BF, Weissman D.

J Exp Med. 2018 Jun 4;215(6):1571-1588. doi: 10.1084/jem.20171450. Epub 2018 May 8.

5.

Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells.

Syrett CM, Sindhava V, Hodawadekar S, Myles A, Liang G, Zhang Y, Nandi S, Cancro M, Atchison M, Anguera MC.

PLoS Genet. 2017 Oct 9;13(10):e1007050. doi: 10.1371/journal.pgen.1007050. eCollection 2017 Oct.

6.

Signals that drive T-bet expression in B cells.

Myles A, Gearhart PJ, Cancro MP.

Cell Immunol. 2017 Nov;321:3-7. doi: 10.1016/j.cellimm.2017.09.004. Epub 2017 Sep 11.

7.

The clinical use of Arthur Boothroyd (AB) word lists in Australia: exploring evidence-based practice.

Myles AJ.

Int J Audiol. 2017 Nov;56(11):870-875. doi: 10.1080/14992027.2017.1327123. Epub 2017 May 22.

PMID:
28532206
8.

A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens.

Sindhava VJ, Oropallo MA, Moody K, Naradikian M, Higdon LE, Zhou L, Myles A, Green N, Nündel K, Stohl W, Schmidt AM, Cao W, Dorta-Estremera S, Kambayashi T, Marshak-Rothstein A, Cancro MP.

J Clin Invest. 2017 May 1;127(5):1651-1663. doi: 10.1172/JCI89931. Epub 2017 Mar 27.

9.

Age-Associated B Cells Express a Diverse Repertoire of VH and Vκ Genes with Somatic Hypermutation.

Russell Knode LM, Naradikian MS, Myles A, Scholz JL, Hao Y, Liu D, Ford ML, Tobias JW, Cancro MP, Gearhart PJ.

J Immunol. 2017 Mar 1;198(5):1921-1927. doi: 10.4049/jimmunol.1601106. Epub 2017 Jan 16.

10.

Chemotherapy can induce weight normalization of morbidly obese mice despite undiminished ingestion of high fat diet.

Myers CE, Hoelzinger DB, Truong TN, Chew LA, Myles A, Chaudhuri L, Egan JB, Liu J, Gendler SJ, Cohen PA.

Oncotarget. 2017 Jan 17;8(3):5426-5438. doi: 10.18632/oncotarget.14576.

11.

Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis.

Gaur P, Myles A, Misra R, Aggarwal A.

Clin Exp Immunol. 2017 Feb;187(2):234-241. doi: 10.1111/cei.12880. Epub 2016 Oct 28.

12.

Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells.

Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, Bengsch B, Linderman SL, Stelekati E, Spolski R, Wherry EJ, Hunter C, Hensley SE, Leonard WJ, Cancro MP.

J Immunol. 2016 Aug 15;197(4):1023-8. doi: 10.4049/jimmunol.1600522. Epub 2016 Jul 18.

13.

The NIK of time for B cells.

Myles A, Cancro MP.

Eur J Immunol. 2016 Mar;46(3):547-51. doi: 10.1002/eji.201646294.

14.

Antibacterial properties of F-doped ZnO visible light photocatalyst.

Podporska-Carroll J, Myles A, Quilty B, McCormack DE, Fagan R, Hinder SJ, Dionysiou DD, Pillai SC.

J Hazard Mater. 2017 Feb 15;324(Pt A):39-47. doi: 10.1016/j.jhazmat.2015.12.038. Epub 2015 Dec 28.

PMID:
26782784
15.

Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.

Reddy VV, Myles A, Cheekatla SS, Singh S, Aggarwal A.

Int J Rheum Dis. 2014 Mar;17(3):261-7. doi: 10.1111/1756-185X.12196. Epub 2014 Jan 13.

PMID:
24417800
16.

TLR4 endogenous ligand MRP8/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression.

Rahman MT, Myles A, Gaur P, Misra R, Aggarwal A.

Rheumatology (Oxford). 2014 Feb;53(2):270-4. doi: 10.1093/rheumatology/ket375. Epub 2013 Nov 14.

PMID:
24231443
17.

Synovial fluid mononuclear cell gene expression profiling suggests dysregulation of innate immune genes in enthesitis-related arthritis patients.

Myles A, Tuteja A, Aggarwal A.

Rheumatology (Oxford). 2012 Oct;51(10):1785-9. Epub 2012 Jul 4.

PMID:
22763987
18.
20.

Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.

Viswanath V, Myles A, Dayal R, Aggarwal A.

J Rheumatol. 2011 Nov;38(11):2482-7. doi: 10.3899/jrheum.110352. Epub 2011 Sep 1.

PMID:
21885500
21.
22.
23.
24.

Water-soluble J-type rosette nanotubes with giant molar ellipticity.

Borzsonyi G, Beingessner RL, Yamazaki T, Cho JY, Myles AJ, Malac M, Egerton R, Kawasaki M, Ishizuka K, Kovalenko A, Fenniri H.

J Am Chem Soc. 2010 Nov 3;132(43):15136-9. doi: 10.1021/ja105028w.

PMID:
20936820
25.

Rosette nanotubes with 1.4 nm inner diameter from a tricyclic variant of the Lehn-Mascal G--C base.

Borzsonyi G, Johnson RS, Myles AJ, Cho JY, Yamazaki T, Beingessner RL, Kovalenko A, Fenniri H.

Chem Commun (Camb). 2010 Sep 21;46(35):6527-9. doi: 10.1039/c0cc01859g. Epub 2010 Aug 12.

PMID:
20714559
26.

Self-assembled rosette nanotube/hydrogel composites for cartilage tissue engineering.

Chen Y, Bilgen B, Pareta RA, Myles AJ, Fenniri H, Ciombor DM, Aaron RK, Webster TJ.

Tissue Eng Part C Methods. 2010 Dec;16(6):1233-43. doi: 10.1089/ten.TEC.2009.0400. Epub 2010 Apr 12.

PMID:
20184414
27.

One-pot nucleation, growth, morphogenesis, and passivation of 1.4 nm Au nanoparticles on self-assembled rosette nanotubes.

Chhabra R, Moralez JG, Raez J, Yamazaki T, Cho JY, Myles AJ, Kovalenko A, Fenniri H.

J Am Chem Soc. 2010 Jan 13;132(1):32-3. doi: 10.1021/ja908775g.

28.

Biologically inspired rosette nanotubes and nanocrystalline hydroxyapatite hydrogel nanocomposites as improved bone substitutes.

Zhang L, Rodriguez J, Raez J, Myles AJ, Fenniri H, Webster TJ.

Nanotechnology. 2009 Apr 29;20(17):175101. doi: 10.1088/0957-4484/20/17/175101. Epub 2009 Apr 3.

PMID:
19420581
29.

Interactive peritoneum in a haptic surgery illustration environment.

Myles A, Yeo YI, Kim M, Cendan J, Kurenov S, Peters J.

Stud Health Technol Inform. 2009;142:221-3.

PMID:
19377154
30.

The role of RGD-tagged helical rosette nanotubes in the induction of inflammation and apoptosis in human lung adenocarcinoma cells through the P38 MAPK pathway.

Suri SS, Rakotondradany F, Myles AJ, Fenniri H, Singh B.

Biomaterials. 2009 Jun;30(17):3084-90. doi: 10.1016/j.biomaterials.2009.02.014. Epub 2009 Feb 27.

PMID:
19250666
31.

Arginine-glycine-aspartic acid modified rosette nanotube-hydrogel composites for bone tissue engineering.

Zhang L, Rakotondradany F, Myles AJ, Fenniri H, Webster TJ.

Biomaterials. 2009 Mar;30(7):1309-20. doi: 10.1016/j.biomaterials.2008.11.020. Epub 2008 Dec 13.

PMID:
19073342
32.

Fatty tissue in a haptic illustration environment.

Punak S, Kim M, Myles A, Cendan J, Kurenov S, Peters J.

Stud Health Technol Inform. 2008;132:384-6.

PMID:
18391326
34.

Exceptionally strong electronic communication through hydrogen bonds in porphyrin-C60 pairs.

Sánchez L, Sierra M, Martín N, Myles AJ, Dale TJ, Rebek J Jr, Seitz W, Guldi DM.

Angew Chem Int Ed Engl. 2006 Jul 10;45(28):4637-41. No abstract available.

PMID:
16791901
35.

Lower rim mono-functionalization of resorcinarenes.

Hauke F, Myles AJ, Rebek J Jr.

Chem Commun (Camb). 2005 Sep 7;(33):4164-6. Epub 2005 Jul 25.

PMID:
16100590
36.

Transfer of multivariate calibrations between four near-infrared spectrometers using orthogonal signal correction.

Woody NA, Feudale RN, Myles AJ, Brown SD.

Anal Chem. 2004 May 1;76(9):2595-600.

PMID:
15117203
37.

Controlling photoinduced electron transfer within a hydrogen-bonded porphyrin-phenoxynaphthacenequinone photochromic system.

Myles AJ, Branda NR.

J Am Chem Soc. 2001 Jan 10;123(1):177-8. No abstract available.

PMID:
11273616
38.

Novel synthesis of photochromic polymers via ROMP.

Myles AJ, Zhang Z, Liu G, Branda NR.

Org Lett. 2000 Sep 7;2(18):2749-51.

PMID:
10964356
39.

Desperately seeking 'specialist practitioner'?

Myles A.

Paediatr Nurs. 1997 Dec;9(10):14. No abstract available.

PMID:
9464069
40.

Polymyalgia rheumatica and giant cell arteritis.

Myles AB.

BMJ. 1995 Nov 4;311(7014):1232. No abstract available.

41.

Non-surgical management of the carpal tunnel syndrome.

Myles AB, Macsweeney S.

Br J Rheumatol. 1995 Sep;34(9):890-1. No abstract available.

PMID:
7582735
42.

Accreditation of prior achievements.

Myles A.

Nurs Stand. 1995 Jul 5-11;9(41):28-9.

PMID:
7654533
43.

Mast cell tryptase levels in normal canine tissues.

Myles AD, Halliwell RE, Ballauf B, Miller HR.

Vet Immunol Immunopathol. 1995 Jun;46(3-4):223-35.

PMID:
7502484
44.

A district audit on the management of polymyalgia rheumatica and giant cell arteritis.

Myles AB.

Br J Rheumatol. 1994 Jul;33(7):690. No abstract available.

PMID:
8019805
45.

Analysis and modelling of the structures of beta-cyclodextrin complexes.

Myles AM, Barlow DJ, France G, Lawrence MJ.

Biochim Biophys Acta. 1994 Jan 5;1199(1):27-36.

PMID:
8280750
46.

Steroid treatment in giant cell arteritis.

Myles AB.

Br J Rheumatol. 1992 Nov;31(11):787. No abstract available.

PMID:
1296626
47.

Prevention of blindness in giant cell arteritis by corticosteroid treatment.

Myles AB, Perera T, Ridley MG.

Br J Rheumatol. 1992 Feb;31(2):103-5.

PMID:
1737222
48.

Prognosis of polymyalgia rheumatica and giant cell arteritis.

Myles AB.

Baillieres Clin Rheumatol. 1991 Dec;5(3):493-503. Review.

PMID:
1807824
49.

Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritis.

Bowness P, Shotliff K, Middlemiss A, Myles AB.

Br J Rheumatol. 1991 Oct;30(5):349-51.

PMID:
1913003
50.

Palmitoylated proteins in Ureaplasma urealyticum.

Thirkell D, Myles AD, Russell WC.

Infect Immun. 1991 Mar;59(3):781-4.

Supplemental Content

Support Center